Transvaginal Doppler sonography for evaluation of irregular uterine bleeding with DMPA

Background The main cause for discontinuation of depot medroxyprogesterone acetate (DMPA) use is irregular menstrual bleeding. The exact pathophysiological mechanisms of irregular bleeding have remained unclear. Transvaginal Doppler is a non-invasive method for studying changes in blood flow which may highlight the underlying pathology in those cases with irregular uterine bleeding. The aim of this study was to quantify the uterine and subendometrial microvasculature in DMPA users with irregular bleeding pattern in comparison to DMPA users with amenorrhea. Study design This is a case control study. Forty users of DMPA were divided into two groups: one group included 20 users with irregular uterine bleeding and the second group included 20 amenorrheic users. Pulsatility index (PI) and resistance index (RI) of uterine and subendometrial blood vessels were determined. Power Doppler Energy was used to quantify the signal percentage of the subendometrial area.

There is significant reduction of PI and RI in the uterine artery and subendometrial microvasculature in cases of irregular uterine bleeding.

Irregular uterine bleeding with DMPA associated with increased perfusion of uterine and subendometrial blood vessels. Similar content being viewed by others

Westhoff C (2003) Depot-medroxyprogesterone acetate injection (Depo-ProveraR): a highly effective contraceptive option with proven long term safety. Contraception 68:75–87 Clark MK, Sower M, Levy BT, Tenhundfeld P (2001) Magnitude and variability of sequential estradiol and progesterone concentration in women using depot medroxyprogesterone acetate for contraception. Fertil Steril 75:179–185 Senthong AJ, Taneepanichskul S (2009) The effect of tranexamic acid for treatment irregular uterine bleeding secondary to DMPA use. J Med Assoc Thai 92(4):461–465 Arias RD, Jain JK, Brucker C, Ross D, Ray A (2006) Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg. Contraception 74(3):234–238 Nathirojanakun P, Taneepanichskul S, Sappakitkumjorn N (2006) Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users. Contraception 73(6):584–587 Gamal D, El-Geleel MA (2008) Color Doppler study of the subendometrial area (junctional zone) of the uterus in unexplained infertility. Middle East Fertil Soc J 13(2):102–110 Jimenez MF, Passos EP, Fagundes PAP et al (2005) Subendometrial power Doppler quantification: a new classification proposal. Reprod Biomed Online 11:232–235 Piya-Anant M, Koetsawang S, Patrasupapong N et al (1998) Effectiveness of cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea. Contraception 57:23–28 French RS, Cowan FM, Mansour D et al (2000) Levonorgestrel-releasing (20 mg/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives. BJOG 107:1218–1225 Abdel-Aleem H, Shaaban OM, Kroosh SS, Abdel-Aleem AM (2005) Endometrium of progestogen only contraceptive users “contact-hysteroscopy and immunohistpathological evaluation”. In: 6th international scientific meeting of the royal college of obstetricians and gynecologists, Cairo, Egypt Runic R, Schatz F, Wan L et al (2000) Effects of norplant on endometrial tissue factor expression and vessel structure. J Clin Endocrinol Metab 85:3853–3859 Krikun G, Critchley H, Schatz F et al (2002) Abnormal uterine bleeding during progestin-only contraception may result from free radical-induced alterations in angiopoietin expression. Am J Pathol 161:979–986 Bettocchi S, Loverro G, Passini N et al (1996) The role of contact hysteroscopy. J Am Assoc Gynecol Laparosc 3(4):635–641 Dane B, Akca A, Dane C, Evcimen S, Cetin Ahmet (2009) Comparison of the effects of the levonorgestrel-releasing intrauterine system (Mirena1) and depot-medroxyprogesterone acetate (Depo-Provera1) on subendometrial microvascularisation and uterine artery blood flow. Eur J Contracept Reprod Health Care 14(3):240–244 Haberal A, Kayıkcıoglu F, Gunes M et al (2006) The effect of the Levonorgestrel intrauterine system on uterine artery blood flow 1 year after insertion. Ultrasound Obstet Gynecol 27:316–319 Jime’nez MF, Arbo E, Vetori D et al (2008) The effect of the levonorgestrel-releasing intrauterine system and the copper intrauterine device on subendometrial microvascularization and uterine artery blood flow. Fertil Steril 90:1574–1578 Alvarez-Sanchez F, Brache V, Thevenin F et al (1996) Hormonal treatment for bleeding irregularities in Norplant implant users. Am J Obstet Gynecol 174:919–922 Jain JK, Nicosia AF, Nucatola DL et al (2003) Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate. Steroids 68:1115–1119 Phupong V, Sophonsritsuk A, Taneepanichskul S (2006) The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use. Contraception 73:253–256 Abdel-Aleem H, d’Arcangues C, Vogelsong KM et al (2007) Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev 2:CD003449 Weisberg E, Hickey M, Palmer D et al (2006) A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. Hum Reprod 21:295–302 Conflict of interest statement None. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Hussein, M. Transvaginal Doppler sonography for evaluation of irregular uterine bleeding with DMPA. Arch Gynecol Obstet 283, 1325–1328 (2011). https://doi.org/10.1007/s00404-010-1569-z Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00404-010-1569-z